NYSE:FMS - Fresenius Medical Care Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$50.55 +0.13 (+0.26 %)
(As of 05/24/2018 09:55 AM ET)
Previous Close$50.55
Today's Range$50.55 - $50.55
52-Week Range$44.88 - $57.94
Volume102 shs
Average Volume118,864 shs
Market Capitalization$31.10 billion
P/E Ratio22.91
Dividend Yield0.86%
Beta0.62

About Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care logoFresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNYSE:FMS
CUSIPN/A
Phone49-6172-6090

Debt

Debt-to-Equity Ratio0.53
Current Ratio1.26
Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio22.91
Forward P/E Ratio19.22
P/E Growth2.75

Sales & Book Value

Annual Sales$20.09 billion
Price / Sales1.54
Cash Flow$3.5624 per share
Price / Cash14.19
Book Value$21.88 per share
Price / Book2.31

Profitability

EPS (Most Recent Fiscal Year)$2.21
Net Income$1.45 billion
Net Margins7.29%
Return on Equity11.09%
Return on Assets4.92%

Miscellaneous

Employees114,000
Outstanding Shares612,900,000

Fresenius Medical Care (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care's stock symbol?

Fresenius Medical Care trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?

Fresenius Medical Care declared an annual dividend on Thursday, May 10th. Stockholders of record on Tuesday, May 22nd will be given a dividend of $0.436 per share on Monday, June 4th. This represents a dividend yield of 0.86%. The ex-dividend date is Monday, May 21st. View Fresenius Medical Care's Dividend History.

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care (NYSE:FMS) released its earnings results on Thursday, May, 3rd. The company reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by $0.21. The firm had revenue of $3.98 billion for the quarter, compared to analysts' expectations of $4.07 billion. Fresenius Medical Care had a return on equity of 11.09% and a net margin of 7.29%. Fresenius Medical Care's revenue was down 12.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.01 EPS. View Fresenius Medical Care's Earnings History.

When is Fresenius Medical Care's next earnings date?

Fresenius Medical Care is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Fresenius Medical Care.

What price target have analysts set for FMS?

7 brokerages have issued 12-month price targets for Fresenius Medical Care's stock. Their predictions range from $44.00 to $62.00. On average, they anticipate Fresenius Medical Care's stock price to reach $53.00 in the next twelve months. View Analyst Ratings for Fresenius Medical Care.

Who are some of Fresenius Medical Care's key competitors?

Who are Fresenius Medical Care's key executives?

Fresenius Medical Care's management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56)

Has Fresenius Medical Care been receiving favorable news coverage?

Media coverage about FMS stock has been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Fresenius Medical Care earned a news impact score of 0.12 on Accern's scale. They also gave press coverage about the company an impact score of 48.22 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Fresenius Medical Care's major shareholders?

Fresenius Medical Care's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Northern Trust Corp (0.13%), Royal Bank of Canada (0.10%), Thornburg Investment Management Inc. (0.06%), US Bancorp DE (0.05%), Allianz Asset Management GmbH (0.05%) and Allianz Asset Management GmbH (0.05%). View Institutional Ownership Trends for Fresenius Medical Care.

Which major investors are selling Fresenius Medical Care stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Boston Partners, US Bancorp DE, Bbva Compass Bancshares Inc., Allianz Asset Management GmbH, Allianz Asset Management GmbH, A.R.T. Advisors LLC and Intrust Bank NA. View Insider Buying and Selling for Fresenius Medical Care.

Which major investors are buying Fresenius Medical Care stock?

FMS stock was purchased by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., Millennium Management LLC, Sivik Global Healthcare LLC, Royal Bank of Canada, Barclays PLC, Wells Fargo & Company MN, Aperio Group LLC and Northern Trust Corp. View Insider Buying and Selling for Fresenius Medical Care.

How do I buy shares of Fresenius Medical Care?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care's stock price today?

One share of FMS stock can currently be purchased for approximately $50.63.

How big of a company is Fresenius Medical Care?

Fresenius Medical Care has a market capitalization of $31.10 billion and generates $20.09 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $2.21 on an earnings per share basis. Fresenius Medical Care employs 114,000 workers across the globe.

How can I contact Fresenius Medical Care?

Fresenius Medical Care's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-6090 or via email at [email protected]


MarketBeat Community Rating for Fresenius Medical Care (FMS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  219 (Vote Outperform)
Underperform Votes:  321 (Vote Underperform)
Total Votes:  540
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fresenius Medical Care (NYSE:FMS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Fresenius Medical Care in the last 12 months. Their average twelve-month price target is $53.00, suggesting that the stock has a possible upside of 4.85%. The high price target for FMS is $62.00 and the low price target for FMS is $44.00. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.572.572.502.43
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.00$53.00$53.00$44.00
Price Target Upside: 4.85% upside7.79% upside0.68% upside9.13% downside

Fresenius Medical Care (NYSE:FMS) Consensus Price Target History

Price Target History for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2018Royal Bank of CanadaReiterated RatingNeutralLowView Rating Details
4/24/2018Deutsche BankUpgradeHold ➝ BuyLowView Rating Details
4/23/2018DZ BankReiterated RatingBuyHighView Rating Details
1/4/2018UBSUpgradeSell ➝ NeutralLowView Rating Details
1/2/2018Nord/LBReiterated RatingBuyLowView Rating Details
12/21/2017SunTrust BanksSet Price TargetBuy$62.00LowView Rating Details
12/11/2017Morgan StanleyDowngradeOverweight ➝ Equal WeightLowView Rating Details
3/12/2017Sanford C. BernsteinReiterated RatingBuyLowView Rating Details
2/24/2017Societe GeneraleDowngradeBuy ➝ HoldN/AView Rating Details
12/14/2016JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
10/18/2016CitigroupReiterated RatingBuyN/AView Rating Details
9/21/2016Goldman Sachs GroupReiterated RatingBuyN/AView Rating Details
8/9/2016Berenberg BankReiterated RatingBuyN/AView Rating Details
7/8/2016Jefferies GroupUpgradeUnderperform ➝ HoldN/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

Fresenius Medical Care (NYSE:FMS) Earnings History and Estimates Chart

Earnings by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Earnings Estimates

2018 EPS Consensus Estimate: $2.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.61$0.61$0.61
Q2 20181$0.64$0.64$0.64
Q3 20181$0.66$0.66$0.66
Q4 20181$0.66$0.66$0.66
Q1 20191$0.67$0.67$0.67
Q2 20191$0.69$0.69$0.69
Q3 20191$0.70$0.70$0.70

Fresenius Medical Care (NYSE FMS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2018        
5/3/20183/31/2018$0.70$0.49$4.0674 billion$3.9760 billionViewN/AView Earnings Details
2/26/2018Q4 2017$0.61$0.69$5.3703 billion$5.2160 billionViewN/AView Earnings Details
11/2/2017Q3 2017$0.61$0.59$5.3643 billion$5.0932 billionViewN/AView Earnings Details
8/1/20176/30/2017$0.53$0.48$5.2028 billion$4.4710 billionViewListenView Earnings Details
5/3/2017Q2$0.44$0.53$4.6874 billion$4.5480 billionViewListenView Earnings Details
2/22/2017Q416$0.62$0.63$4.74 billion$4.6870 billionViewListenView Earnings Details
10/27/2016Q316$0.52$0.54$4.55 billion$4.5980 billionViewListenView Earnings Details
8/1/2016Q216$0.49$0.48$4.54 billion$4.42 billionViewN/AView Earnings Details
5/3/2016Q116$0.42$0.37$4.25 billion$4.2050 billionViewN/AView Earnings Details
2/24/2016Q415$0.58$0.52$4.41 million$4.35 millionViewListenView Earnings Details
10/29/2015Q3$0.45$0.43$4.2749 billion$4.2310 billionViewListenView Earnings Details
7/30/2015Q215$0.42$0.40$4.13 billion$4.1990 billionViewListenView Earnings Details
4/30/2015Q1$0.40$0.35$3.8873 billion$3.96 billionViewN/AView Earnings Details
2/25/2015Q4$0.49$0.56$4.2301 billion$4.32 billionViewN/AView Earnings Details
11/4/2014Q3$0.44$0.45$3.9443 billion$4.1130 billionViewN/AView Earnings Details
7/31/2014Q2$0.41$0.39$3.8350 billionViewN/AView Earnings Details
5/6/2014Q1 2014$0.38$0.34$3.6045 billion$3.5640 billionViewN/AView Earnings Details
2/25/2014Q4$0.53$0.58$3.8464 billion$3.8670 billionViewN/AView Earnings Details
11/5/2013$0.45$0.47$3.6427 billion$3.6661 billionViewN/AView Earnings Details
7/30/2013$0.46$0.43$3.6147 billion$3.6125 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.45$0.37$3.4997 billion$3.4639 billionViewN/AView Earnings Details
2/26/2013Q4 2012$0.52$1.07ViewN/AView Earnings Details
10/31/2012Q3 2012$0.49$0.22ViewN/AView Earnings Details
8/1/2012Q2 2012$0.46$0.44ViewN/AView Earnings Details
5/3/2012Q1 2012$0.42$0.40ViewN/AView Earnings Details
2/21/2012Q4 2011$0.51$0.51ViewN/AView Earnings Details
11/3/2011Q3 2011$0.47$0.46ViewN/AView Earnings Details
8/2/2011Q2 2011$0.43$0.43ViewN/AView Earnings Details
5/4/2011Q1 2011$0.38$0.37ViewN/AView Earnings Details
2/23/2011Q4 2010$0.44$0.45ViewN/AView Earnings Details
11/2/2010Q3 2010$0.42$0.41ViewN/AView Earnings Details
8/3/2010Q2 2010$0.40$0.42ViewN/AView Earnings Details
5/4/2010Q1 2010$0.37$0.35ViewN/AView Earnings Details
2/24/2010Q4 2009$0.40$0.41ViewN/AView Earnings Details
11/3/2009Q3 2009$0.38$0.38ViewN/AView Earnings Details
8/4/2009Q2 2009$0.37$0.37ViewN/AView Earnings Details
4/30/2009Q1 2009$0.33$0.34ViewN/AView Earnings Details
2/19/2009Q4 2008$0.36$0.36ViewN/AView Earnings Details
11/4/2008Q3 2008$0.35$0.35ViewN/AView Earnings Details
7/30/2008Q2 2008$0.34$0.36ViewN/AView Earnings Details
4/30/2008Q1 2008$0.31$0.32ViewN/AView Earnings Details
2/20/2008Q4 2007$0.31$0.34ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Fresenius Medical Care (NYSE:FMS) Dividend Information

Fresenius Medical Care pays an annual dividend of $0.44 per share, with a dividend yield of 0.87%. FMS's next annual dividend payment will be made on Monday, June 4. The company has grown its dividend for the last 2 consecutive years and is increasing its dividend by an average of 0.20% each year. Fresenius Medical Care pays out 19.91% of its earnings out as a dividend.
Next Dividend:6/4/2018
Annual Dividend:$0.44
Dividend Yield:0.87%
Dividend Growth:0.20% (3 Year Average)
Payout Ratio(s):19.91% (Trailing 12 Months of Earnings)
16.73% (Based on This Year's Estimates)
15.44% (Based on Next Year's Estimates)
12.35% (Based on Cash Flow)
Track Record:2 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE:FMS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/10/2018Annual$0.43600.86%5/21/20185/22/20186/4/2018
4/24/2017annual$0.51371.17%5/11/20175/15/20175/26/2017
3/9/2016$0.30405/10/20165/12/20165/23/2016
5/2/2014annual$0.53351.57%5/13/20145/15/20145/27/2014
5/14/2013annual$0.49041.42%5/14/20135/16/20135/28/2013
(Data available from 1/1/2013 forward)

Insider Trades

Fresenius Medical Care (NYSE FMS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 2.48%
Insider Trading History for Fresenius Medical Care (NYSE:FMS)
Institutional Ownership by Quarter for Fresenius Medical Care (NYSE:FMS)

Fresenius Medical Care (NYSE FMS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Fresenius Medical Care (NYSE FMS) News Headlines

Source:
DateHeadline
Fresenius Medical Care (FMS) Shares Cross Below 200 DMAFresenius Medical Care (FMS) Shares Cross Below 200 DMA
www.nasdaq.com - May 23 at 4:07 PM
Fresenius Medical Care (FMS) Receives Consensus Rating of "Hold" from BrokeragesFresenius Medical Care (FMS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 20 at 5:30 PM
Fresenius Medical Care (FMS) Investor Presentation - SlideshowFresenius Medical Care (FMS) Investor Presentation - Slideshow
seekingalpha.com - May 18 at 4:07 PM
Fresenius Medical Care Sees Continued Strong Growth; AGM Okays Dividend IncreaseFresenius Medical Care Sees Continued Strong Growth; AGM Okays Dividend Increase
www.nasdaq.com - May 17 at 10:16 AM
Fresenius Medical Care (FMS) Declares $0.44 Annual DividendFresenius Medical Care (FMS) Declares $0.44 Annual Dividend
www.americanbankingnews.com - May 16 at 11:16 AM
Here's Why You Should Sell Fresenius Medical (FMS) Stock NowHere's Why You Should Sell Fresenius Medical (FMS) Stock Now
finance.yahoo.com - May 14 at 4:02 PM
Heres Why You Should Sell Fresenius Medical (FMS) Stock NowHere's Why You Should Sell Fresenius Medical (FMS) Stock Now
www.zacks.com - May 14 at 11:00 AM
Comparing Caladrius Biosciences (CLBS) & Fresenius Medical Care (FMS)Comparing Caladrius Biosciences (CLBS) & Fresenius Medical Care (FMS)
www.americanbankingnews.com - May 12 at 5:11 PM
Fresenius Medical Care (FMS) Downgraded by Zacks Investment ResearchFresenius Medical Care (FMS) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 9 at 5:12 PM
Fresenius Medical (FMS) Misses on Q1 Earnings, Lowers ViewFresenius Medical (FMS) Misses on Q1 Earnings, Lowers View
www.zacks.com - May 9 at 10:00 AM
Catasys (CATS) and Fresenius Medical Care (FMS) Head-To-Head ReviewCatasys (CATS) and Fresenius Medical Care (FMS) Head-To-Head Review
www.americanbankingnews.com - May 8 at 12:48 PM
Fresenius Medical Care (FMS) Issues  Earnings Results, Misses Estimates By $0.21 EPSFresenius Medical Care (FMS) Issues Earnings Results, Misses Estimates By $0.21 EPS
www.americanbankingnews.com - May 5 at 4:54 PM
Edited Transcript of FME.DE earnings conference call or presentation 3-May-18 1:30pm GMTEdited Transcript of FME.DE earnings conference call or presentation 3-May-18 1:30pm GMT
finance.yahoo.com - May 5 at 10:16 AM
Fresenius Medical Care (FMS) Receives "Neutral" Rating from Royal Bank of CanadaFresenius Medical Care (FMS) Receives "Neutral" Rating from Royal Bank of Canada
www.americanbankingnews.com - May 4 at 12:21 AM
Fresenius Medical Care Q1 Profit Down 10%; Affirms FY18 Outlook - Quick FactsFresenius Medical Care Q1 Profit Down 10%; Affirms FY18 Outlook - Quick Facts
www.nasdaq.com - May 3 at 9:49 AM
Here's Why Akorn Inc Fell as Much as 16.4% TodayHere's Why Akorn Inc Fell as Much as 16.4% Today
finance.yahoo.com - May 2 at 4:06 PM
RenalSense Announces Distribution Agreement With Fresenius Medical CareRenalSense Announces Distribution Agreement With Fresenius Medical Care
finance.yahoo.com - April 30 at 10:12 AM
Jefferies Group Weighs in on Fresenius Medical Cares FY2018 Earnings (FMS)Jefferies Group Weighs in on Fresenius Medical Care's FY2018 Earnings (FMS)
www.americanbankingnews.com - April 30 at 3:44 AM
Equities Analysts Issue Forecasts for Fresenius Medical Cares FY2021 Earnings (FMS)Equities Analysts Issue Forecasts for Fresenius Medical Care's FY2021 Earnings (FMS)
www.americanbankingnews.com - April 27 at 11:14 AM
Reviewing Tivity Health (TVTY) and Fresenius Medical Care (FMS)Reviewing Tivity Health (TVTY) and Fresenius Medical Care (FMS)
www.americanbankingnews.com - April 26 at 11:35 AM
Contrasting Catasys (CATS) & Fresenius Medical Care (FMS)Contrasting Catasys (CATS) & Fresenius Medical Care (FMS)
www.americanbankingnews.com - April 26 at 8:04 AM
Fresenius Medical Care (FMS) to Release Quarterly Earnings on ThursdayFresenius Medical Care (FMS) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - April 26 at 2:50 AM
Fresenius Medical Care (FMS) Given Consensus Recommendation of "Buy" by BrokeragesFresenius Medical Care (FMS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 25 at 5:30 PM
Fresenius Medical Care (FMS) Upgraded to Buy at Deutsche BankFresenius Medical Care (FMS) Upgraded to Buy at Deutsche Bank
www.americanbankingnews.com - April 24 at 9:12 AM
Jilted Akorn sues Fresenius over deal terminationJilted Akorn sues Fresenius over deal termination
finance.yahoo.com - April 23 at 4:02 PM
Fresenius Medical Care (FMS) Stock Rating Reaffirmed by DZ BankFresenius Medical Care (FMS) Stock Rating Reaffirmed by DZ Bank
www.americanbankingnews.com - April 23 at 8:12 AM
Fresenius Medical cuts 2018 sales target after drug dosage shiftFresenius Medical cuts 2018 sales target after drug dosage shift
finance.yahoo.com - April 22 at 4:38 PM
Fresenius Medical Cares (FMS) "Sell" Rating Reaffirmed at UBSFresenius Medical Care's (FMS) "Sell" Rating Reaffirmed at UBS
www.americanbankingnews.com - April 20 at 12:58 AM
Fresenius Medical Care (FMS) Lifted to "Buy" at Zacks Investment ResearchFresenius Medical Care (FMS) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 19 at 12:02 PM
Fresenius Medical Care (FMS) Downgraded by BidaskClub to BuyFresenius Medical Care (FMS) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - April 16 at 8:40 PM
Fresenius Medical Care (FMS) Downgraded to Hold at BidaskClubFresenius Medical Care (FMS) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - April 14 at 10:53 PM
Royal Bank of Canada Reaffirms Neutral Rating for Fresenius Medical Care (FMS)Royal Bank of Canada Reaffirms Neutral Rating for Fresenius Medical Care (FMS)
www.americanbankingnews.com - April 12 at 9:35 PM
Heres Why You Should Invest in Fresenius Medical Right NowHere's Why You Should Invest in Fresenius Medical Right Now
finance.yahoo.com - April 10 at 10:24 AM
Fresenius Medical Care (FMS) Stock Rating Lowered by Zacks Investment ResearchFresenius Medical Care (FMS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:49 AM
DZ Bank Reiterates Buy Rating for Fresenius Medical Care (FMS)DZ Bank Reiterates Buy Rating for Fresenius Medical Care (FMS)
www.americanbankingnews.com - April 5 at 12:26 PM
Fresenius Medical Care AG & Co. (FMS) Given Consensus Recommendation of "Buy" by AnalystsFresenius Medical Care AG & Co. (FMS) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 31 at 5:42 PM
Fresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Nord/LBFresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Nord/LB
www.americanbankingnews.com - March 31 at 1:34 PM
Can Fresenius Medical Care AG & Co KGaA (ETR:FME) Continue To Outperform Its Industry?Can Fresenius Medical Care AG & Co KGaA (ETR:FME) Continue To Outperform Its Industry?
finance.yahoo.com - March 29 at 4:01 PM
Fresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Royal Bank of CanadaFresenius Medical Care AG & Co. (FMS) Stock Rating Reaffirmed by Royal Bank of Canada
www.americanbankingnews.com - March 24 at 11:12 PM
Does Fresenius Medical Care AG & Co KGaA’s (ETR:FME) PE Ratio Signal A Buying Opportunity?Does Fresenius Medical Care AG & Co KGaA’s (ETR:FME) PE Ratio Signal A Buying Opportunity?
finance.yahoo.com - March 20 at 3:56 PM
3 Favorable Trends Dispelling Tax-Repeal Worries in MedTech3 Favorable Trends Dispelling Tax-Repeal Worries in MedTech
finance.yahoo.com - March 20 at 3:56 PM
Fresenius Medical (FMS) Q4 Earnings Beat, View ImpressiveFresenius Medical (FMS) Q4 Earnings Beat, View Impressive
finance.yahoo.com - March 8 at 4:42 PM
Fresenius Medical Care AG & Co. (FMS) Stock Rating Upgraded by Zacks Investment ResearchFresenius Medical Care AG & Co. (FMS) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - March 8 at 8:40 AM
Fresenius Medical Care AG & Co. (FMS) Receives Average Recommendation of "Hold" from AnalystsFresenius Medical Care AG & Co. (FMS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 6 at 5:26 PM
Fresenius Medical Care AG & Co. (FMS) Shares Bought by Suntrust Banks Inc.Fresenius Medical Care AG & Co. (FMS) Shares Bought by Suntrust Banks Inc.
www.americanbankingnews.com - March 3 at 9:56 AM
Acadia Healthcare (ACHC) and Fresenius Medical Care AG & Co. (FMS) Head-To-Head ReviewAcadia Healthcare (ACHC) and Fresenius Medical Care AG & Co. (FMS) Head-To-Head Review
www.americanbankingnews.com - March 2 at 1:16 AM
The Providence Service (PRSC) versus Fresenius Medical Care AG & Co. (FMS) Financial ReviewThe Providence Service (PRSC) versus Fresenius Medical Care AG & Co. (FMS) Financial Review
www.americanbankingnews.com - March 1 at 9:14 PM
Fresenius Medical Care AG & Co. (FMS) Earns Buy Rating from DZ BankFresenius Medical Care AG & Co. (FMS) Earns Buy Rating from DZ Bank
www.americanbankingnews.com - February 28 at 4:34 PM
Bbva Compass Bancshares Inc. Reduces Position in Fresenius Medical Care AG & Co. (FMS)Bbva Compass Bancshares Inc. Reduces Position in Fresenius Medical Care AG & Co. (FMS)
www.americanbankingnews.com - February 28 at 5:02 AM
Fresenius Medical Care AG & Co. (FMS) Posts  Earnings Results, Beats Expectations By $0.57 EPSFresenius Medical Care AG & Co. (FMS) Posts Earnings Results, Beats Expectations By $0.57 EPS
www.americanbankingnews.com - February 27 at 5:32 PM

SEC Filings

Fresenius Medical Care (NYSE:FMS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fresenius Medical Care (NYSE:FMS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fresenius Medical Care (NYSE FMS) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.